Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inmune Bio, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-18Dec-31-17
   10-K10-K
Net income  -12.4-0.8
Stock-based compensation  10.00.2
Change in working capital  1.70.3
Other operating activities  -1.3-0.4
Cash from operations  -2.1-0.8
   
Capital expenditures  0.00.0
Purchases of intangible assets   -0.1
Cash from investing  0.0-0.1
   
Issuance of common stock, net  0.92.1
Cash from financing  0.92.1
   
Free cash flow  -2.1-0.8
        Per share (diluted)  ($0.24)($0.12)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy